156 related articles for article (PubMed ID: 32166965)
1. Role of renal sympathetic denervation in hypertension.
Lateef N; Virk HU; Khan MS; Lakhter V; Haseeb A; Ahsan MJ; Mirza M; Rangaswami J; Zidar DA; Holmberg M; Janzer S
Future Cardiol; 2020 Jul; 16(4):211-216. PubMed ID: 32166965
[No Abstract] [Full Text] [Related]
2. The Ongoing Odyssey of Renal Denervation.
Vinayak M; Olin JW; Stone GW
J Am Coll Cardiol; 2023 Nov; 82(19):1824-1827. PubMed ID: 37914511
[No Abstract] [Full Text] [Related]
3. Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis.
Ewen S; Meyer MR; Cremers B; Laufs U; Helfer AG; Linz D; Kindermann I; Ukena C; Burnier M; Wagenpfeil S; Maurer HH; Böhm M; Mahfoud F
Clin Res Cardiol; 2015 Dec; 104(12):1097-105. PubMed ID: 26306594
[TBL] [Abstract][Full Text] [Related]
4. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.
; Esler MD; Krum H; Sobotka PA; Schlaich MP; Schmieder RE; Böhm M
Lancet; 2010 Dec; 376(9756):1903-9. PubMed ID: 21093036
[TBL] [Abstract][Full Text] [Related]
5. Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension.
Desch S; Okon T; Heinemann D; Kulle K; Röhnert K; Sonnabend M; Petzold M; Müller U; Schuler G; Eitel I; Thiele H; Lurz P
Hypertension; 2015 Jun; 65(6):1202-8. PubMed ID: 25824248
[TBL] [Abstract][Full Text] [Related]
6. In hypertension not treated with medications, renal denervation vs. sham reduced daytime ambulatory SBP at 2 mo.
Samuels JA; Molony DA
Ann Intern Med; 2023 Jun; 176(6):JC68. PubMed ID: 37276593
[TBL] [Abstract][Full Text] [Related]
7. Adherence to Antihypertensive Treatment and the Blood Pressure-Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial.
Azizi M; Pereira H; Hamdidouche I; Gosse P; Monge M; Bobrie G; Delsart P; Mounier-Véhier C; Courand PY; Lantelme P; Denolle T; Dourmap-Collas C; Girerd X; Michel Halimi J; Zannad F; Ormezzano O; Vaïsse B; Herpin D; Ribstein J; Chamontin B; Mourad JJ; Ferrari E; Plouin PF; Jullien V; Sapoval M; Chatellier G;
Circulation; 2016 Sep; 134(12):847-57. PubMed ID: 27576780
[TBL] [Abstract][Full Text] [Related]
8. Randomized comparison of renal denervation versus intensified pharmacotherapy including spironolactone in true-resistant hypertension: six-month results from the Prague-15 study.
Rosa J; Widimský P; Toušek P; Petrák O; Čurila K; Waldauf P; Bednář F; Zelinka T; Holaj R; Štrauch B; Šomlóová Z; Táborský M; Václavík J; Kociánová E; Branny M; Nykl I; Jiravský O; Widimský J
Hypertension; 2015 Feb; 65(2):407-13. PubMed ID: 25421981
[TBL] [Abstract][Full Text] [Related]
9. Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension).
Gosse P; Cremer A; Pereira H; Bobrie G; Chatellier G; Chamontin B; Courand PY; Delsart P; Denolle T; Dourmap C; Ferrari E; Girerd X; Michel Halimi J; Herpin D; Lantelme P; Monge M; Mounier-Vehier C; Mourad JJ; Ormezzano O; Ribstein J; Rossignol P; Sapoval M; Vaïsse B; Zannad F; Azizi M
Hypertension; 2017 Mar; 69(3):494-500. PubMed ID: 28115517
[TBL] [Abstract][Full Text] [Related]
10. Five special focuses of Hypertension Research: digital hypertension, home blood pressure-centered approach, renal denervation, Asians, for guidelines.
Kario K; Hoshide S; Mogi M
Hypertens Res; 2023 Dec; 46(12):2557-2560. PubMed ID: 38049635
[No Abstract] [Full Text] [Related]
11. [Denervation denuded].
de Leeuw PW
Ned Tijdschr Geneeskd; 2014; 158():A7832. PubMed ID: 24988175
[TBL] [Abstract][Full Text] [Related]
12. Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects.
Kjeldsen SE; Os I; Mahfoud F
EuroIntervention; 2013 May; 9 Suppl R():R7-9. PubMed ID: 23732159
[No Abstract] [Full Text] [Related]
13. Renal denervation in treatment-resistant hypertension: the need for restraint and more and better evidence.
Persu A; Renkin J; Asayama K; O'Brien E; Staessen JA
Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):739-49. PubMed ID: 23750683
[TBL] [Abstract][Full Text] [Related]
14. [Renal denervation a treatment for resistant hypertension: a French experience].
Benamer H; Mylotte D; Garcia-Alonso C; Unterseeh T; Garot P; Louvard Y; Lefevre T; Morice MC;
Ann Cardiol Angeiol (Paris); 2013 Dec; 62(6):384-91. PubMed ID: 24182849
[TBL] [Abstract][Full Text] [Related]
15. Renal denervation trials in hypertension - what we wait for in 2023/2024.
Mahfoud F; Kunz M; Götzinger F
Eur J Intern Med; 2023 Nov; 117():55-56. PubMed ID: 37730516
[No Abstract] [Full Text] [Related]
16. Renal denervation in patients with chronic kidney disease: current evidence and future perspectives.
Schmieder RE
Nephrol Dial Transplant; 2023 May; 38(5):1089-1096. PubMed ID: 35617138
[TBL] [Abstract][Full Text] [Related]
17. The Rise and Fall and Rise of Renal Denervation.
Bhatt DL
J Am Coll Cardiol; 2022 Nov; 80(20):1881-1883. PubMed ID: 36357088
[No Abstract] [Full Text] [Related]
18. Renal sympathetic denervation in Sweden: a report from the Swedish registry for renal denervation.
Völz S; Spaak J; Elf J; Jägrén C; Lundin C; Stenborg A; Andersson J; Rundqvist B; Kahan T; Andersson B
J Hypertens; 2018 Jan; 36(1):151-158. PubMed ID: 29210862
[TBL] [Abstract][Full Text] [Related]
19. Screening for non-adherence to antihypertensive treatment as a part of the diagnostic pathway to renal denervation.
Patel P; Gupta PK; White CM; Stanley AG; Williams B; Tomaszewski M
J Hum Hypertens; 2016 Jun; 30(6):368-73. PubMed ID: 26446393
[TBL] [Abstract][Full Text] [Related]
20. Are we on the path to solve the enigma of resistant hypertension: renal sympathetic denervation.
Gerc V; Buksa M
Med Arch; 2013 Dec; 67(6):454-9. PubMed ID: 25568521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
